Kolexia
De Luna Gonzalo
Médecine interne
Hôpital Henri Mondor
Créteil, France
147 Activités
558 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose COVID-19 Vascularite Granulomatose avec polyangéite Anémie Troubles du rythme cardiaque Tachycardie ventriculaire Hémolyse Infections à coronavirus

Industries

GLOBAL BLOOD THERAPEUTICS FRANCE SAS
5 collaboration(s)
Dernière en 2022
Celgene
4 collaboration(s)
Dernière en 2021
Bluebird
4 collaboration(s)
Dernière en 2021
PATIENTYS
2 collaboration(s)
Dernière en 2023

Dernières activités

New Insights into VOC Incidence By Analyzing the Single Cell Quantification of HbF per RBC and Mchbs
65th ASH Annual Meeting Abstracts   02 novembre 2023
Fetal Hemoglobin Decrease during Voxelotor Treatment
65th ASH Annual Meeting Abstracts   02 novembre 2023
Atrial Arrhythmia in Sickle Cell Anemia: A Missing Piece to Prevent Cerebrovascular Complications?
65th ASH Annual Meeting Abstracts   02 novembre 2023
Double-Blind Randomized Study to Evaluate the Effect of Hydroxycarbamide on Albuminuria in Adults with Sickle Cell Disease: Sikamic (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Drepadom - a Homecare Protocol for Vaso-Occlusive Crisis for Sickle Cell Disease Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
New Insights in Sickle Cell Disease Provided By Intravascular Hemolysis and Total Hb Mass Parameters
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optimizing Albuminuria Assessment in Patients with Sickle Cell Disease: Insights from the Sikamic Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.
Haematologica   19 octobre 2023
HEMOPROVE: HEMolyse and Organ Damage imPROvement in Sickle Cell Disease by VoxElotor. An Open-label One Stage Phase II Design
Essai Clinique (Pfizer)   19 septembre 2023